Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATAI LIFE SCIENCES N.V.

(ATAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Atai Life Sciences N.V.
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The company is aiming to transform the treatment of mental health disorders.

Number of employees : 48 people.
Managers
Name Title Age Since
Florian Brand Chief Executive Officer 33 2018
Gregory L. Weaver Chief Financial Officer 64 2020
Srinivas G. Rao, Dr. Chief Scientific Officer 51 2018
Rolando GutÝerrez-Esteinou, Dr. Chief Medical Officer 59 2021
Alexis Marc Joel Louis de Rosnay Independent Member-Supervisory Board 52 -
Sabrina Martucci Johnson Independent Member-Supervisory Board 65 -
Amir H. Kalali, Dr. Independent Member-Supervisory Board 54 -
Andrea Heslin Smiley Independent Member-Supervisory Board 52 -
Members of the board
Name Title Age Since
Christian Angermayer Member-Supervisory Board 43 2018
Michael B. Auerbach Member-Supervisory Board 44 -
Jason Camm Member-Supervisory Board 31 -
Alexis Marc Joel Louis de Rosnay Independent Member-Supervisory Board 52 -
Sabrina Martucci Johnson Independent Member-Supervisory Board 65 -
Amir H. Kalali, Dr. Independent Member-Supervisory Board 54 -
Andrea Heslin Smiley Independent Member-Supervisory Board 52 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 152,569,776 137,813,232 90.3% 0 0.0% 90.3%
Shareholders
NameEquities%
Apeiron Investment Group Ltd. /Private Equity/ 29,692,304 19.2%
Galaxy Group Investments LLC 9,196,736 5.94%
Michael B. Auerbach 5,564,474 3.59%
Falcon Edge Capital LP 2,626,473 1.70%
Pura Vida Investments LLC 1,371,824 0.89%
Morgan Stanley Investment Management, Inc. 980,276 0.63%
Woodline Partners LP 791,585 0.51%
Citadel Advisors LLC 651,488 0.42%
T. Rowe Price Associates, Inc. (Investment Management) 650,000 0.42%
Northern Light Management AB 600,000 0.39%
Holdings
NameEquities%Valuation
INTELGENX TECHNOLOGIES CORP. (IGXT) 37,300,000 33.3% 14,920,000 USD
Brand Portfolio
In partnership withAllbrands.markets
More brands of Atai Life Sciences N.V.
Sector Other Biotechnology & Medical Research